JAK2 and thrombocytosis disease: To test this, we employed a JAK2 V617F transgenic mouse model, which mirrors PV natural history, with erythrocytosis, granulocytosis, thrombocytosis, splenomegaly and eventually anemia and osteomyelofibrosis (68).